2013
DOI: 10.1016/j.psyneuen.2012.07.013
|View full text |Cite
|
Sign up to set email alerts
|

Intranasal oxytocin attenuates the cortisol response to physical stress: A dose–response study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

9
85
0
2

Year Published

2014
2014
2019
2019

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 177 publications
(96 citation statements)
references
References 57 publications
9
85
0
2
Order By: Relevance
“…Considering the increased risk of crossreactivity with arginine vasopressin (AVP) receptors with higher OT doses (Åkerlund et al, 1999;Cho et al, 1999;Manning et al, 2012), which may disrupt the balance of brain OT and AVP (Neumann and Landgraf, 2012), it is important to determine if lower doses can match, or improve, the reported effects of OT (Churchland and Winkielman, 2012). Intriguingly, converging evidence from human and animal research indicates that under some circumstances, lower OT dose may offer similar or stronger effects than larger doses in comparison (Bales et al, 2013;Benelli et al, 1995;Cardoso et al, 2013;Hall et al, 2012;Popik et al, 1992;Van IJzendoorn et al, 2012). However, research is yet to comprehensively compare the impact of different IN-OT doses on social cognition and behavior.…”
Section: Resultsmentioning
confidence: 99%
“…Considering the increased risk of crossreactivity with arginine vasopressin (AVP) receptors with higher OT doses (Åkerlund et al, 1999;Cho et al, 1999;Manning et al, 2012), which may disrupt the balance of brain OT and AVP (Neumann and Landgraf, 2012), it is important to determine if lower doses can match, or improve, the reported effects of OT (Churchland and Winkielman, 2012). Intriguingly, converging evidence from human and animal research indicates that under some circumstances, lower OT dose may offer similar or stronger effects than larger doses in comparison (Bales et al, 2013;Benelli et al, 1995;Cardoso et al, 2013;Hall et al, 2012;Popik et al, 1992;Van IJzendoorn et al, 2012). However, research is yet to comprehensively compare the impact of different IN-OT doses on social cognition and behavior.…”
Section: Resultsmentioning
confidence: 99%
“…The following were used as criteria for excluding participation: current medical illness, existing physical injury, current recreational drug use or past history of drug use (with the exception of cannabis, which required 1-year abstinence), use of current medications including psychotropic medication, history of psychiatric disorders, and prior or current use of psychological treatment services. Only participants in good physical condition were recruited to participate in the study because the larger data collection required participants to run on a treadmill for 60 minutes (Cardoso, Ellenbogen, Orlando, et al, 2013). This project was approved by the Human Research Ethics Committee at Concordia University (Montréal, Canada).…”
Section: Methods Participantsmentioning
confidence: 99%
“…Similarly, the optimal dose for an OXT IN -based intervention is still elusive. In voles, the propensity to display behaviors such as pair bonding is modulated in a dose-dependent manner (142), and in humans, 24-IU, but not 48-IU, of OXT IN attenuates cortisol levels in response to physical stress (143). The selectivity of OXT for the OXTR relative to AVPRs is at least twentyfold (cf.…”
Section: Translational Implications and New Avenues For Future Researchmentioning
confidence: 99%